Puma Biotechnology Inc (PBYI)


Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Puma Biotechnology Inc chart...

About the Company

we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.

Exchange

NASDAQ

Website

pumabiotechnology.com

$66M

Total Revenue

292

Employees

$222M

Market Capitalization

21.05

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PBYI News

Puma Biotechnology dips after dismissal of its suit was granted by a federal judge

5h ago, source: Seeking Alpha on MSN

Puma Biotechnology (NASDAQ:PBYI) fell over 6% on Monday after a federal judge granted AstraZeneca's (AZN) motion to dismiss ...

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript

16d ago, source:

Q4 2023 Earnings Call February 29, 2024 Puma Biotechnology, Inc. misses on earnings expectations. Reported EPS is $0.26 EPS, ...

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates

17d ago, source: Zacks.com on MSN

Puma Biotechnology, Inc. PBYI reported fourth-quarter 2023 adjusted earnings of 31 cents per share, which missed the Zacks ...

Buy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement Prospects

17d ago, source:

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Puma Biotechnology (PBYI – Research Report). The associated ...

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director

12d ago, source:

Michael J. Finney, Ph.D. to Continue as Chairman of the Board of DirectorsSOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- ...

Puma Biotech: Q4 Earnings Snapshot

19d ago, source: Houston Chronicle

LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported profit of $12.3 million in its fourth quarter. The Los Angeles-based company said it had net income of 26 ...

Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise

14d ago, source: Zacks.com on MSN

However, the top line missed the Zacks Consensus Estimate of $3.9 million.Branded business grew 3%, driven by brands like ...

Apple in discussions to allow Google's Gemini power iPhone AI features: report

on MSN ago, source:

Apple is reportedly in talks with Google to license its artificial intelligence model, Gemini to power some iPhone features.

The Squishmallows x Puma Super Plush Sneaker Collection Is On Sale Now

3d ago, source:

Before we get into the details of the Puma x Squishmallows collection, let's cover the really important bit. The sneakers ...

All Brands

2y ago, source: PC Magazine

PCMag.com is a leading authority on technology, delivering lab-based, independent reviews of the latest products and services. Our expert industry analysis and practical solutions help you make better ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...